Clinical trial · Observational
Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR)
NCT03807492CI-TRIAL-00089707completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The EMPOWeR study is proposed as a cohort study with longitudinal follow-up to determine rates of genetic mutations among men with or at-risk for prostate cancer to address the various facets of genetic education and counseling for optimized genetic assessment and wellness of men. The results will inform practice guidelines and future studies for maximal impact of genetic evaluation of men for inherited prostate cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- EMPOWeR Study
- description
- This is a cohort study, with initial patient assessments and longitudinal follow-up. Participation of subjects will be indefinite, which will be discussed in the informed consent.
Primary outcomes (1)
- measure
- Perform genetic testing for men with or at-risk for prostate cancer to determine association of mutations to patient characteristics.
- timeFrame
- 6 months
- description
- Participants will undergo gene panel testing through a saliva or blood sample. A genetic test summary will be generated to give to participants at disclosure of results. Participants will receive genetic test results in person, by phone or via telehealth. Fisher's exact test will be used to determine association of mutations and variants to patient characteristics.
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Men with a personal history of prostate cancer * Unaffected males who are at higher risk for prostate cancer (family history of prostate cancer or African American males) * Men who previously tested positive for a mutation may be eligible for Specific Aims 2-7 * Men with a known familial mutation * Men who previously participated in the Genetic Evaluation of Men (GEM) study (IRB#14S.546) will be offered participation in EMPOWeR - Exclusion Criteria: * Age \< 18 years * Mental or cognitive impairment that interferes with ability to provide informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.